Advanced BRAFV600 Wild-type Melanoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Advanced BRAFV600 Wild-type Melanoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

CompletedPhase 2

NCT04059224

TraMel-WT: A Trial of Trametinib in Patients With Advanced Pretreated BRAFV600 Wild-type Melanoma

This phase 2 trial will investigate the efficacy and safety of trametinib and dabrafenib in patients with advanced BRAF V600 (v-Raf murine sarcoma viral oncogen…

Belgium45 participantsStarted 2019-01-28

Treatment: Trametinib, Dabrafenib

TerminatedPhase 3

NCT03273153

A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv60…

This is a Phase III, multicenter, open-label, randomized study designed to evaluate the efficacy, safety, and pharmacokinetics of cobimetinib plus atezolizumab…

United States446 participantsStarted 2017-12-11

Treatment: Cobimetinib, Atezolizumab